Zura Bio Limited

Historical 13F Holders

Symbol
ZURA
CUSIP
G9TY5A101
All holders as of
Q3 2026
Type
Equity
Class
CLASS A ORD SHS
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for G9TY5A101 since 12/18/2024, largest first.

Filer % of Class Filed
AI Biotechnology LLC 13D/A
18.2% 3/2/2026
Event 2/26/2026
Athanor Capital 13D
15.7% 1/27/2026
Event 1/23/2026
Venrock Healthcare Capital Partners III, L.P. 13G/A
9.9% 5/15/2026
Event 3/31/2026
Suvretta Capital Management, LLC 13G/A
9.9% 5/12/2026
Event 3/31/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (6)
RA Capital Management, L.P. 13G/A
4.9% 2/14/2025
Event 12/31/2024
JPMorgan Chase & Co 13G/A 4.7% 5/6/2026
Event 4/30/2026
Pfizer Inc 13G/A 4.6% 2/12/2025
Event 12/31/2024
Great Point Partners, LLC 13G/A
4.4% 5/15/2026
Event 3/31/2026
ADAR1 Capital Management, LLC 13G/A
3.2% 2/14/2025
Event 12/31/2024
Deep Track Capital, LP 13G/A
0.4% 11/14/2025
Event 9/30/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 123 69.3 M $288M
2026 Q2 97 72.9 M $429M
2026 Q1 94 66.1 M $392M
2025 Q4 74 44.9 M $235M
2025 Q3 66 41.1 M $178M
2025 Q2 65 35.3 M $37.1M
2025 Q1 75 45.7 M $59.0M
2024 Q4 88 42.9 M $107M
2024 Q3 79 37.2 M $151M
2024 Q2 58 32.9 M $115M
2024 Q1 46 14.9 M $37.6M
2023 Q4 45 15.2 M $70.7M
2023 Q3 42 14.1 M $93.3M
2023 Q2 39 12.8 M $105M
2023 Q1 3 25.7 k $24.7k